Kalil and Stebbing published their data in The Lancet Respiratory Medicine on 1st September. Antibacterial, antifungal, antiviral, and antiparasitic treatments developed in the past century have improved survival outcomes, even in high-mortality conditions such as...
The editorial published in The Lancet August 28th 2021 reviews this. As the COVID-19 pandemic continues, the need to understand and respond to long COVID is increasingly pressing. Symptoms such as persistent fatigue, breathlessness, brain fog and depression could...
Huang and others published this study in The Lancet August 28th 2021. The full range of long term health consequences of COVID-19 in patients who are discharged from hospital is largely unclear. The aim of this study was to comprehensively compare...
Safety of the messenger RNA Pfizer vaccine was evaluated by Barda and others and published in the New England Journal of Medicine on August 25th. Background trials showed that messenger RNA based vaccines against severe acute respiratory syndrome coronavirus,...
Professor Stebbing in his daily update expands on this. He suggests that there are falls in cases across two out of the five European countries but also a continued increase in the number of sick patients in hospital in the United Kingdom, Italy and...
An interesting paper published in the New England Journal of Medicine describes this as a vaccine which could prevent infection caused by known and future variants of concern as well as infection with pre-emergent sarbecoviruses i.e. those with potential to cause...
